Dimitrios Pappas
Visiting Associate Professor
N/A
School of Medicine
Visiting Professor
Academic Qualifications
| Qualification | Year | Awarding Institution | Department |
| MD | 1999 | Aristotle University of Thessaloniki | Medicine |
| Internal Medicine Residency | 2006 | Albany Medical College | Medicine |
| Rheumatology Fellowship | 2009 | Johns Hopkins University | Medicine |
| Master of Public Health | 2012 | Johns Hopkins University | Epidemiology and Biostatitics |
Employment History
| Qualification | Year | Awarding Institution | Department |
| MD | 1999 | Aristotle University of Thessaloniki | Medicine |
| Internal Medicine Residency | 2006 | Albany Medical College | Medicine |
| Rheumatology Fellowship | 2009 | Johns Hopkins University | Medicine |
| Asst Professor of Medicine | 2009-2010 | Johns Hopkins, Baltimore, MD, USA | Medicine |
| Asst Professor of Medicine | 2010 until now | Columbia University, New York, NY, USA | Medicine |
| Master of Public Health | 2012 | Johns Hopkins University | Epidemiology and Biostatitics |
Publications
| Ref. Number | Year | Title | Other authors | Journal and Publisher / Conference | Vol. | Pages |
| PMID: 24390342 | 2014 | Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014 Feb 20;506(7488):376-81 | Okada Y, Wu D, Gosia Trynka, Towfique Raj, Chikashi Terao, Katsunori Ikari, Kochi Y, Ohmura K, Suzuki A, Yoshida S, Robert R. Graham RR, Manoharan A, Ortmann W, Bhangale T, Denny JC , Carroll RJ,. Eyler AE, Greenberg JD, Kremer JM, Pappas DA, et a | Nature. | 506(7488) | 376-81 |
| PMID: 32719038. | 2020 | Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study. | Pappas DA, St John G, Etzel CJ, Fiore S, Blachley T, Kimura T, Punekar R, Emeanuru K, Choi J, Boklage S, Kremer JM | Ann Rheum Dis. 2021 | 80(1) | 96-102. |
| PMID: 31342661 | 2019 | Machine Learning to Predict Anti-Tumor Necrosis Factor Drug Responses of Rheumatoid Arthritis Patients by Integrating Clinical and Genetic Markers. | Guan Y, Zhang H, Quang D, Wang Z, Parker SCJ, Pappas DA, Kremer JM, Zhu F. | Arthritis Rheumatol | 71(12): | 1987-1996. |
| PMID: 19721444 | 2009 | Golimumab | Pappas DA, Bathon JM, Hanicq D, Yasothan U, Kirkpatrick P. | Nature Reviews Drug Discovery | 8(9) | 695-6 |
Exhibitions
| Date | Topic | International / Local | Location* | Role in Exhibition |
| Yearly | American Collegen of Rheumatolgy | International | USA | Presenter |
Research Projects
| Date | Title | Funded by | Project Role* |
| Current | Design and launching of observational registries in the United States and Internationally | CorEvitas | Scientific Director |
Academic Consulting Services/Councils/Boards/Editorial Committees
| Period | Organization | Title of Position or Service | Key Activities |
| 2009 – Current | Consortium of Rheumatology Researchers of North America | Board of Directors | Original research publications in rheumatoid arthrtisi |
| 2013 – Current | Athens Medical Center | Director, Division of Rheumatology | Directorship of Rheumatology Division |
Awards/International Recognition
| Date | Title | Awarded by: |
| 2007 | MARC fellowship award | Arthritis Foundation |